HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis

Authors: Wang, Hong ^{a, b, 1}, Qian, Dong ^{b, 1}, Wang, Jiabei ^{a, c}, Liu, Yao ^{a, c}, Luo, Wenguang ^b, Zhang, Hongyan ^b, Cheng, Jingjing ^b, Li, Heng ^{a, d}, Wu, Yang ^{a, e}, Li, Wuhan ^f, Wang, Jing ^{g, h}, Yang, Xia ⁱ, Zhang, Tianzhi ^j, Han, Dong ^k, Wang, Qinyao ^l, Zhang, Chris Zhiyi ^{m, ⁎}, Liu, Lianxin ^{a, c, ⁎}

Source: In Journal of Advanced Research February 2025 68:257-270

EFHD1, a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma

Authors: Meng, Kun, Hu, Yuyu, Wang, Dingkang, Li, Yuying, Shi, Fujin, Lu, Jiangli, Wang, Yang, Cao, Yun, Zhang, Chris Zhiyi, He, Qing‐Yu

Source: Cancer science. 114(5):2029-2040

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181645731.0x000001&indx=1&recIds=ETOCvdc_100181645731.0x000001

A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma

Authors: Meng, Kun, Li, Yu-Ying, Liu, Dan-Ya, Hu, Li-Ling, Pan, Yun-Long, Zhang, Chris Zhiyi, He, Qing-Yu

Source: In Computational and Structural Biotechnology Journal 2023 21:2621-2630

The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis.

Authors: Meng, Kun, Li, Yuying, Yuan, Xiaoyi, Shen, Hui-Min, Hu, Li-Ling, Liu, Danya, Shi, Fujin, Zheng, Dandan, Shi, Xinyu, Wen, Nengqiao, Cao, Yun, Pan, Yun-Long, He, Qing-Yu, Zhang, Chris Zhiyi

Source: Signal Transduction & Targeted Therapy; 1/27/2025, Vol. 10 Issue 1, p1-17, 17p

PPM1G‐mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma.

Authors: Hu, Liling, Shi, Xinyu, Yuan, Xiaoyi, Liu, Danya, Zheng, Dandan, Li, Yuying, Shi, Fujin, Zhang, Meifang, Su, Shu‐Guang, Zhang, Chris Zhiyi

Source: Cancer Science; Jan2025, Vol. 116 Issue 1, p67-80, 14p

Temporal dynamics of immune cell patterns in bladder cancer patients receiving Bacillus Calmette-Guérin therapy: Clinical Studies.

Authors: Lu, Jiang-Li, Ye, Yun-Lin, Zheng, Dan-Dan, Shi, Xin-Yu, Hu, Li-Ling, Yuan, Xiao-Yi, Cai, Tao-Nong, Meng, Kun, Wen, Neng-Qiao, Li, Yu-Ying, Wang, Ding-Kang, Shi, Fu-Jin, Liu, Dan-Ya, He, Qing-Yu, Qin, Zi-Ke, Zhang, Chris Zhiyi, Cao, Yun

Source: British Journal of Cancer; Dec2024, Vol. 131 Issue 12, p1901-1912, 12p

LINC00493‐encoded microprotein SMIM26 exerts anti‐metastatic activity in renal cell carcinoma

Authors: Meng, Kun, Lu, Shaohua, Li, Yu‐Ying, Hu, Li‐Ling, Zhang, Jing, Cao, Yun, Wang, Yang, Zhang, Chris Zhiyi, He, Qing‐Yu

Source: EMBO reports. 24(6)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184656533.0x000001&indx=1&recIds=ETOCvdc_100184656533.0x000001

CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma

Authors: Jiang, Nan, Niu, Gang, Pan, Ying-Hua, Pan, Wenwei, Zhang, Mei-Fang, Zhang, Chris Zhiyi, Shen, Huimin

Source: In EBioMedicine March 2020 53

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways

Authors: Chen, Shi‐Lu, Liu, Li‐Li, Wang, Chun‐Hua, Lu, Shi‐Xun, Yang, Xia, He, Yang‐Fan, Zhang, Chris Zhiyi, Yun, Jing‐Ping

Source: Molecular oncology. 14(2):373-386

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120662665.0x000001&indx=1&recIds=ETOCvdc_100120662665.0x000001

Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials

Authors: Wong, Jack Ho, Ng, Tzi Bun, Chan, Helen Hei Ling, Liu, Qin, Man, Gene Chi Wai, Zhang, Chris Zhiyi, Guan, Suzhen, Ng, Charlene Cheuk Wing, Fang, Evandro Fei, Wang, Hexiang, Liu, Fang, Ye, Xiuyun, Rolka, Krzysztof, Naude, Ryno, Zhao, Shuang, Sha, Ou, Li, Chunman, Xia, Lixin

Source: Applied microbiology and biotechnology. 104(11):4675-4703

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167907297.0x000001&indx=1&recIds=ETOCvdc_100167907297.0x000001

Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma

Authors: Lu, Shi-Xun, Zhang, Chris Zhiyi, Luo, Rong-Zhen, Wang, Chun-Hua, Liu, Li-Li, Fu, Jia, Zhang, Lanjing, Wang, Huamin, Xie, Dan, Yun, Jing-Ping

Source: In Cancer Letters 28 August 2017 402:71-80

Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Authors: Zheng, Dan-Dan, Li, Yu-Ying, Yuan, Xiao-Yi, Lu, Jiang-Li, Zhang, Mei-Fang, Fu, Jia, Zhang, Chris Zhiyi

Source: BMC Cancer; 5/27/2024, Vol. 24 Issue 1, p1-12, 12p

Subject Terms: ESOPHAGEAL cancer, IMMUNE checkpoint proteins, SQUAMOUS cell carcinoma, CELL aggregation, PATHOLOGIC complete response, CHEMORADIOTHERAPY

miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33

Authors: Zhang, Chris Zhiyi, Cao, Yun, Fu, Jia, Yun, Jing-Ping, Zhang, Mei-Fang

Source: In Molecular Oncology December 2016 10(10):1532-1541

Pan-Cancer Proteomics Analysis Reveals Wiskott–Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1

Authors: Hu, Liling, Liu, Danya, Zheng, Dandan, Lu, Jiangli, Yuan, Xiaoyi, Li, Yuying, Shi, Fujin, Shi, Xinyu, He, Qing-Yu, Li, Qiuli, Zhang, Chris Zhiyi

Source: Journal of Proteome Research; June 2024, Vol. 23 Issue: 6 p2195-2205, 11p

Retracted:HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis

Authors: Chen, Shi‐Lu, Liu, Li‐Li, Lu, Shi‐Xun, Luo, Rong‐Zhen, Wang, Chun‐Hua, Wang, Hong, Cai, Shao‐Hang, Yang, Xia, Xie, Dan, Zhang, Chris Zhiyi, Yun, Jing‐Ping

Source: Molecular oncology. 11(9):1225-1240

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167376537.0x000001&indx=1&recIds=ETOCvdc_100167376537.0x000001

Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo

Authors: Zhang, Chris Zhiyi, Zhang, Haitao, Yun, Jingping, Chen, George Gong, Lai, Paul Bo San

Source: In Biochemical Pharmacology 1 May 2012 83(9):1278-1289

SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma

Authors: Yang, Yu-Feng, Zhang, Mei-Fang, Tian, Qiu-Hong, Fu, Jia, Yang, Xia, Zhang, Chris Zhiyi, Yang, Hong

Source: Molecular cancer. 17(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128133259.0x000001&indx=1&recIds=ETOCvdc_100128133259.0x000001

Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues.

Authors: Lu, Jiangli, Zhao, Ming, Wu, Chenyan, Chu, Chengbiao, Zhang, Chris Zhiyi, Cao, Yun

Source: Diagnostic Pathology; 1/14/2022, Vol. 17 Issue 1, p1-6, 6p

Subject Terms: TRANSITIONAL cell carcinoma, IMMUNOHISTOCHEMISTRY, UROTHELIUM, TISSUES, BLADDER, STATISTICAL correlation

α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.

Authors: Lu, Shi-Xun, Huang, Yu-Hua, Liu, Li-Li, Zhang, Chris Zhiyi, Yang, Xia, Yang, Yuan-Zhong, Shao, Chun-Kui, Li, Jian-Ming, Xie, Dan, Zhang, Xuchen, Jain, Dhanpat, Yun, Jing-Ping

Source: British Journal of Cancer; Jun2021, Vol. 124 Issue 12, p1988-1996, 9p

A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.

Authors: Wu, Chen-Yan, Li, Lei, Chen, Shi-Lu, Yang, Xia, Zhang, Chris Zhiyi, Cao, Yun

Source: Cell Death & Disease; Apr2021, Vol. 12 Issue 4, p1-11, 11p